tiprankstipranks
Trending News
More News >
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market
Advertisement

Corbus Pharmaceuticals (CRBP) Financial Statements

Compare
2,415 Followers

Corbus Pharmaceuticals Financial Overview

Corbus Pharmaceuticals's market cap is currently $141.67M. The company's EPS TTM is $-1.44; its P/E ratio is ―; Corbus Pharmaceuticals is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-1.71. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

Corbus Pharmaceuticals Debt to Assets

Corbus Pharmaceuticals Cash Flow

Corbus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis